MSCI Inc. (MSCI)
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-11-04
$674.30+5.40%
Close 2026-11-04 · 1-day change
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-11-04
Research Workspace
Put MSCI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 12% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskHealthy across the board
MSCI's recurring fee model must keep compounding to justify the price. Revenue growth is slowing, dropping from 14.1% to 12.4% year over year. The latest quarter beat estimates by 2.6%. The stock trades at 35x earnings versus a 12x peer median. This premium is above its own 33x historical average. The price reflects less growth than our forecast. Index exclusion proposals threaten asset-based fee growth. Our model puts the next-quarter miss probability near 13%. Peer multiples imply a price about 18% below where it trades. Our read remains intact. This read is provisional.
Trailing returns as of 2026-11-04. MSCI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering MSCI (as of Nov 2026).
Based on 9 Wall Street analysts offering 12-month price targets for MSCI in the last 4 months.
Continue this research
Compare MSCI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MSCI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financial Exchanges & Data — fair value, gap to price, and forward P/E.
Compare the value case
Put MSCI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Indonesian president’s accusation raises regulatory and market-access risk after a market rout.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $674.30
The last 12 months of price, then the range of analyst 12-month targets from today’s $674.30.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Indonesia's effort to avert MSCI status risks highlights potential index-classification and asset-based fee exposure.
Advances: Grow free cash flow
Quarterly call provides direct evidence on results, guidance, and cash-flow objectives.
Advances: Grow free cash flow
Earnings beat and affirmed free-cash-flow guidance support financial objectives.
Advances: Grow free cash flow
Surge coverage likely reflects quarterly results and improved company outlook.
MSCI's index-classification decisions reportedly intensified Indonesian market concerns, creating regulatory and reputational risk.
MSCI warning reportedly triggered Indonesian market turmoil, raising market-access and asset-fee risks.
Explains MSCI's dispute with Indonesian stock-market practices and potential consequences for index exposure.
